Immunotherapy in non-small cell lung cancer harbouring driver mutations
Lung cancer is the leading cause of cancer-related death globally [1]. Non-small cell lung cancer (NSCLC) accounts for 85% of all lung cancers, and lung adenocarcinoma (LUAD) is the major subtype of...
cancertreatmentreviews.com